ALAMAR BIOSCIENCES INC
ALMRNASDAQ🏆 #1840 by market capEarnings Nov 3 · PostUS Equity
$34.39▲ $2.49 (+7.82%)
After hours · at closeTrack ALMR
Get earnings, price moves & breaking news on Telegram
24h▲ 7.8%
7d▲ 9.3%
14d▲ 35.6%
30d▲ 5.7%
ytd—
1y—
🏦Market Cap
$2.39B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $32.09 – $34.38
- 52-Week Range
- $18.85 – $39.61
- Volume (shares)
- 120,866
- Avg Volume (shares)
- —
- Shares Outstanding
- 69.4M
- Next Earnings
- 2026-11-03
Fundamentals Snapshot
- Annual Revenue
- $74M
- Last Q Revenue
- $29M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
ALAMAR BIOSCIENCES INC
ALMRFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout ALAMAR BIOSCIENCES INC
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
⚡Momentum★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
11 analysts
Strong Buy4
Buy5
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.